Early intervention with tafamidis provides long-term benefit in delaying neurological progression in patients with transthyretin familial amyloid polyneuropathy

被引：0
|
作者：
Marcia Waddington-Cruz
Leslie Amass
Denis Keohane
Jeffrey Schwartz
Balarama Gundapaneni
Hui Hua Li
机构：
[1] Neuromuscular Diseases Unit,Hospital Universitario Clementino
[2] Pfizer,undefined
[3] Pfizer,undefined
[4] Pfizer,undefined
[5] Pfizer,undefined
[6] Pfizer,undefined
[7] Pfizer,undefined
[8] InVentiv Health,undefined
来源：
Orphanet Journal of Rare Diseases | / 10卷 / Suppl 1期
关键词：
Registration Trial; Open Label Extension; Additional Categorization; Continue Evaluation; Treatment Start;
D O I：
10.1186/1750-1172-10-S1-P12
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Long term effects of tafamidis treatment on transthyretin familial amyloid polyneuropathy (TTR-FAP): interim results from the Fx1A-303 study
    Coelho, T.
    Conceicao, I. M.
    Barroso, F.
    Waddington-Cruz, M.
    Schmidt, H. H. -J.
    Rosas, G.
    Mandel, F. S.
    Stewart, M.
    Huertas, P.
    Karayal, O. N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 81 - 81
  • [42] Long term effects of tafamidis treatment on transthyretin familial amyloid polyneuropathy (TTR-FAP): interim results from the Fx1A-303 study
    Coelho, T.
    Conceicao, I. M.
    Barroso, F.
    Waddington-Cruz, M.
    Schmidt, H. H. -J.
    Rosas, G.
    Mandel, F. S.
    Stewart, M.
    Huertas, P.
    Karayal, O. N.
    JOURNAL OF NEUROLOGY, 2014, 261 : S59 - S60
  • [43] Safety and Efficacy of Long-Term Diflunisal Administration in Familial Amyloid Polyneuropathy
    Sekijima, Yoshiki
    Tojo, Kana
    Morita, Hiroshi
    Koyama, Jun
    Koike, Haruki
    Sobue, Gen
    Ikeda, Shu-Ichi
    NEUROLOGY, 2013, 80
  • [44] Efficacy and safety of long-term administration of diflunisal to familial amyloid polyneuropathy
    Tojo, K.
    Sekijima, Y.
    Morita, H.
    Koyama, J.
    Kodaira, M.
    Tsuchiya-Suzuki, A.
    Yazaki, M.
    Ikeda, S-I.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 76 - 76
  • [45] Response by Elliott et al to Letter Regarding Article, "Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy"
    Elliott, Perry
    Gundapaneni, Balarama
    Sultan, Marla B.
    CIRCULATION-HEART FAILURE, 2022, 15 (07)
  • [46] Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy
    Leslie Amass
    Huihua Li
    Balarama K. Gundapaneni
    Jeffrey H. Schwartz
    Denis J. Keohane
    Orphanet Journal of Rare Diseases, 13
  • [47] Long-Term Serial Echocardiographic Observation in Patients With Familial Amyloid Polyneuropathy After Optimal Therapy
    Koyama, Jun
    Minamisawa, Masatoshi
    Kuwahara, Koichiro
    CIRCULATION, 2018, 138
  • [48] Long-term outcome of liver transplantation for patients with trasthyretin related familial amyloid polyneuropathy (FAP)
    Ohya, Yuki
    Ando, Yukio
    Ueda, Mitsuharu
    Yamamoto, Hidekazu
    Takeichi, Takayuki
    Yamashita, Taro
    Okajima, Hideaki
    Asonuma, Katsuhiro
    Inomata, Yukihiro
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 378 - 378
  • [49] Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy
    Amass, Leslie
    Li, Huihua
    Gundapaneni, Balarama K.
    Schwartz, Jeffrey H.
    Keohane, Denis J.
    ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [50] Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: A Plain Language Summary
    Elliott, Perry
    Drachman, Brian M.
    Gottlieb, Stephen S.
    Hoffman, James E.
    Hummel, Scott L.
    Lenihan, Daniel J.
    Ebede, Ben
    Gundapaneni, Balarama
    Li, Benjamin
    Sultan, Marla B.
    Shah, Sanjiv J.
    FUTURE CARDIOLOGY, 2023, 19 (01) : 7 - 17
12345